Comparison · NCT03348683-1465e083
Propranolol vs Placebo: Number of Fetus With Heart Rate Decelerations
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Propranolol vs Placebo: Number of Fetus With Heart Rate Decelerations. Trial comparisons, record NCT03348683-1465e083. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03348683-1465e083
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.124 | 0.0766 | 0.194 | wilson | |
| Risk in group 2 | 0.109 | 0.065 | 0.178 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0147 | -0.0687 | 0.098 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.13 | 0.564 | 2.28 | log | |
| Odds ratio, group 1 over group 2 | 1.15 | 0.524 | 2.54 | log | |
| Number needed to treat, for one more participant with the outcome on Propranolol than on Placebo | 67.9 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Propranolol | After induction was started with Foley or misoprostol placement, 30 minutes passed before administration of propranolol 2mg of IV push | 15 | 121 | OG000 |
| Group 2 | Placebo | After induction was started with Foley or misoprostol placement, 30 minutes passed before administration of an equivalent quantity in milliliters of IV normal saline | 13 | 119 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Fetus With Heart Rate Decelerations
- Description
- Count of fetus with fetal heart rate decelerations within 30 minutes of study drug administration
- Time frame
- 30 minutes from drug administration
- Population
Source ClinicalTrials.gov
Trial
- Title
- Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients
- NCT number
- NCT03348683
- Phases
- PHASE2
- Conditions
- Induction of Labor Affected Fetus / Newborn
- Interventions
- Propranolol, Placebo
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Results first posted
- 2019-12-26
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03348683?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03348683-1465e083